| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |